Connect Biopharma Holdings Limited
CNTB · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $48 | $1,912 | $24,116 | $0 |
| % Growth | -97.5% | -92.1% | – | – |
| Cost of Goods Sold | $0 | $184 | $0 | $482 |
| Gross Profit | $48 | $1,729 | $23,640 | -$482 |
| % Margin | 100% | 90.4% | 98% | – |
| R&D Expenses | $8,773 | $15,899 | $13,316 | $25,181 |
| G&A Expenses | $4,699 | $11,801 | $7,428 | $11 |
| SG&A Expenses | $4,699 | $11,801 | $7,428 | $5,922 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $5,935 |
| Other Operating Expenses | $0 | -$1,066 | -$3,936 | -$4,354 |
| Operating Expenses | $13,472 | $26,635 | $16,808 | $27,736 |
| Operating Income | -$13,424 | -$24,906 | $7,308 | -$27,230 |
| % Margin | -27,966.7% | -1,302.6% | 30.3% | – |
| Other Income/Exp. Net | $580 | $1,851 | $401 | -$1,636 |
| Pre-Tax Income | -$12,844 | -$23,055 | $7,709 | -$28,867 |
| Tax Expense | $55 | $163 | $60 | $55 |
| Net Income | -$12,899 | -$23,217 | $7,649 | -$28,922 |
| % Margin | -26,872.9% | -1,214.2% | 31.7% | – |
| EPS | -0.23 | -0.42 | 0.14 | -0.52 |
| % Growth | 45.2% | -400% | 126.9% | – |
| EPS Diluted | -0.23 | -0.42 | 0.14 | -0.52 |
| Weighted Avg Shares Out | 55,498 | 55,190 | 55,144 | 55,067 |
| Weighted Avg Shares Out Dil | 55,498 | 55,190 | 55,554 | 55,067 |
| Supplemental Information | – | – | – | – |
| Interest Income | $619 | $4,032 | $822 | -$2,488 |
| Interest Expense | $0 | $0 | $20 | -$10 |
| Depreciation & Amortization | $171 | $184 | $476 | $482 |
| EBITDA | -$13,253 | -$22,871 | $8,195 | -$28,372 |
| % Margin | -27,610.4% | -1,196.1% | 34% | – |